[Safety and efficacy of chimeric antigen receptor T cell in the treatment of elderly patients with hematological malignancies].

Liu, D; Ke, P; Huo, L; Hu, X H; Fu, C C; Li, C X; Huang, H W; Xue, S L; Qiu, H Y; Wu, D P; Ma, X.

Afiliación

Ma X; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Suzhou 215006, China.

Zhonghua Xue Ye Xue Za Zhi ; 39(11): 952-955, 2018 Nov 14.

Article en Zh | MEDLINE | ID: mdl-30486596

Texto completo: 1 Base de datos: MEDLINE Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2018 Tipo del documento: Article